DSS, Inc. Names Jason Grady as Interim Chief Executive Officer
26 août 2024 16h08 HE
|
DSS, Inc.
NEW YORK, Aug. 26, 2024 (GLOBE NEWSWIRE) -- DSS, Inc. (NYSE American: DSS) has announced the appointment of Jason Grady as its Interim CEO, effective August 23, 2024. Grady, who previously served as...
Impact Biomedical, Inc. Announces U.S. Patent Allowance of Laetose™ Technology Entitled "Low Glycemic Sugar Composition."
30 janv. 2024 08h05 HE
|
DSS, Inc.
NEW YORK, Jan. 30, 2024 (GLOBE NEWSWIRE) -- Impact Biomedical Inc. (IBIO), in which DSS Inc.(NYSE American: DSS) has a significant investment, is thrilled to announce a milestone in its innovative...
DSS, Inc. Chairman Chan Acquires 672,173 shares of DSS In Open Market
04 janv. 2024 08h15 HE
|
DSS, Inc.
NEW YORK, Jan. 04, 2024 (GLOBE NEWSWIRE) -- DSS, Inc. (NYSE American: DSS, “Company”), a multinational company operating across four distinct market sectors, announced today a significant investment...
DSS, Inc. Announces Reverse Split as Part of NYSE American Compliance Plan
22 déc. 2023 16h30 HE
|
DSS, Inc.
NEW YORK, Dec. 22, 2023 (GLOBE NEWSWIRE) -- DSS, Inc. (NYSE American: DSS, “Company”), a multinational company operating nine (9) diversified business lines developed through strategic acquisitions...
Premier Packaging, a Wholly-Owned Subsidiary of DSS, Inc., Secures Contract Extension with Major Retailer Worth Up to $15 Million over Four Years
28 nov. 2023 08h10 HE
|
DSS, Inc.
NEW YORK, Nov. 28, 2023 (GLOBE NEWSWIRE) -- DSS, Inc. (NYSE American: DSS), a multinational company operating nine (9) diversified business lines developed through strategic acquisitions to build...
DSS Inc. Wins Patent Dispute with Nichia Corporation
14 nov. 2023 08h00 HE
|
DSS, Inc.
NEW YORK, Nov. 14, 2023 (GLOBE NEWSWIRE) -- DSS, Inc. (NYSE American: DSS) announced today that, in a unanimous decision, the Court of Appeals for the Federal Circuit (CAFC) rejected Nichia...
DSS, Inc. Subsidiary Files Current Report on Form 8-K Disclosing Reverse Split of Outstanding and Issued Common Stock and Conversion of Certain Holder’s Common Stock
08 nov. 2023 08h31 HE
|
DSS, Inc.
NEW YORK, Nov. 08, 2023 (GLOBE NEWSWIRE) -- DSS, Inc. (NYSE American: DSS) announced today that Impact BioMedical Inc. (“Impact”) filed a Current Report on Form 8-K with the Securities and Exchange...
DSS Inc. Receives Notice of Non-Compliance with NYSE American Trading Share Price Listing Rule
26 oct. 2023 17h25 HE
|
DSS, Inc.
NEW YORK, Oct. 26, 2023 (GLOBE NEWSWIRE) -- DSS, Inc.(NYSE American: DSS) announced today that the Company received a letter (the “Letter”) from the staff of NYSE American LLC (the “Exchange”)...
DSS, Inc. Announces Filing of Registration Statement on Form S-1 for Initial Public Offering of Impact Biomedical
23 oct. 2023 08h25 HE
|
DSS, Inc.
NEW YORK, Oct. 23, 2023 (GLOBE NEWSWIRE) -- DSS, Inc.(NYSE American: DSS) ("DSS") announced today that it has filed a registration statement on Form S-1 with the U.S. Securities and Exchange...
DSS Inc. Issues Letter to Shareholders
12 oct. 2023 08h25 HE
|
DSS, Inc.
ROCHESTER, N.Y., Oct. 12, 2023 (GLOBE NEWSWIRE) -- DSS, Inc. (NYSE American: DSS), a multinational company operating nine (9) diversified business lines developed through strategic acquisitions to...